Search Within

Francisco Sanchez Vega

Formats
  1. Journal Article (85)
  2. Meeting Abstract (43)
  3. Editorial (4)
  4. Review (3)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Computational Oncology Service (137)
  2. Epidemiology and Biostatistics (137)
  3. Sloan Kettering Institute Postdocs (137)
  4. Surgery (137)
  5. GSK Faculty (103)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (96)

More Groups

People
  1. Nikolaus Schultz (80)
  2. Walid Chatila (36)
  3. Julio Garcia Aguilar (29)
  4. David Solit (27)
  5. Michael Berger (27)
  6. Ritika Kundra (26)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (9)
  4. 2022 (18)
  5. 2021 (20)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Cancer Research (13)
  3. Nature Communications (13)
  4. Clinical Cancer Research (9)
  5. Cancer Cell (8)
  6. Annals of Oncology (5)

More Publications

Publishers
  1. American Association for Cancer Research (27)
  2. Nature Publishing Group (24)
  3. American Society of Clinical Oncology (22)
  4. Cell Press (16)
  5. Oxford University Press (10)
  6. Springer (6)

More Publishers

Results (137)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation between comprehensive molecular profiling and clinical outcomes in patients with colorectal liver metastases
    Meeting Abstract

    Connell, L. C.; Sanchez-Vega, F.; Boucher, T. M.; Yaeger, R. D.; Schultz, N.; Cercek, A.; Hechtman, J. F.; Kemeny, N. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Characterization of genomic alterations associated with metastatic tropism in a cohort of patients with renal cell carcinoma
    Meeting Abstract

    Becerra, M.; Sanchez-Vega, F.; Reznik, E.; Kashan, M.; Mendonca, S. J.; Manley, B.; Ghanaat, M.; Khan, N.; Coleman, J.; Russo, P.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • The emergence of pan-cancer CIMP and its elusive interpretation
    Journal Article

    Miller, B. F.; Sánchez-Vega, F.; Elnitski, L.
    Biomolecules (2016)

    Fulltext@MSK | Save
  • Recurrent, truncating Sox9 mutations are associated with sox9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma
    Journal Article

    Javier, B. M.; Yaeger, R.; Wang, L.; Sanchez-Vega, F.; Zehir, A.; Middha, S.; Sadowska, J.; Vakiani, E.; Shia, J.; Klimstra, D.; more...
    Oncotarget (2016)

    Fulltext@MSK | Save
  • A multi-method approach for proteomic network inference in 11 human cancers
    Journal Article

    Şenbabaoğlu, Y.; Sümer, S. O.; Sánchez-Vega, F.; Bemis, D.; Ciriello, G.; Schultz, N.; Sander, C.
    PLoS Computational Biology (2016)

    Fulltext@MSK | Save